A Phase 1, Open-Label, Fixed-Sequence, Drug-Drug Interaction Study to Evaluate the Effects of Tucatinib of the Pharmacokinetics of Metformin in Healthy Male and Female Subjects
Latest Information Update: 29 Oct 2020
At a glance
- Drugs Tucatinib (Primary) ; Iohexol; Metformin
- Indications Breast cancer; Cholangiocarcinoma; Colorectal cancer; Gallbladder cancer; Gastrointestinal cancer; Non-small cell lung cancer
- Focus Pharmacokinetics
- Sponsors Seagen; Seattle Genetics
Most Recent Events
- 24 Jun 2020 Results presented at the 111th Annual Meeting of the American Association for Cancer Research - II
- 25 Mar 2019 Status changed from recruiting to completed.
- 28 Feb 2019 Status changed from not yet recruiting to recruiting.